Overcoming the Barriers of Brain Cancer Treatment: Targeted and Fully NIR Absorbing Photodynamic Therapy Agents with Extremely Low Molecular Weights and Controlled Lipophilicity

Project Information

INFRADYNAMICS

Grant agreement ID: 852614

DOI

10.3030/852614

Project closed

EC signature date 18 October 2019

Start date 1 November 2019

End date 31 October 2025

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 1 500 000,00

EU contribution

€ 1 500 000,00

Coordinated by

MIDDLE EAST TECHNICAL UNIVERSITY
Türkiye

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity

Author(s): Toghrul Almammadov, Gizem Atakan, Ozen Leylek, Gulnihal Ozcan, Gorkem Gunbas, Safacan Kolemen
Published in: ACS Medicinal Chemistry Letters, Issue 11/12, 2020, Page(s) 2491-2496, ISSN 1948-5875
Publisher: American Chemical Society
DOI: 10.1021/acsmedchemlett.0c00484

Balanced Intersystem Crossing in Iodinated Silicon-Fluoresceins Allows New Class of Red Shifted Theranostic Agents

Author(s): Sultan Cetin, Zubeyir Elmazoglu, Osman Karaman, Hande Gunduz, Gorkem Gunbas, Safacan Kolemen
Published in: ACS Medicinal Chemistry Letters, Issue 12/5, 2021, Page(s) 752-757, ISSN 1948-5875
Publisher: American Chemical Society
DOI: 10.1021/acsmedchemlett.1c00018

Intellectual Property Rights

Other (1)

NEAR-INFRARED (NIR) ABSORBING PHOTOSENSITIZERS

Application/Publication number: WO /2020/005172
Date: 2018-06-25
Applicant(s): MIDDLE EAST TECHNICAL UNIVERSITY